tamoxifen sandoz 10 mg
sandoz pharmaceuticals d.d., slovinsko - tamoxifén - 44 - cytostatica
tamoxifen sandoz 20 mg
sandoz pharmaceuticals d.d., slovinsko - tamoxifén - 44 - cytostatica
zitazonium 20 mg
egis pharmaceuticals plc, maďarsko - tamoxifén - 44 - cytostatica
zitazonium 10 mg
egis pharmaceuticals plc, maďarsko - tamoxifén - 44 - cytostatica
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
letrozol sandoz 2,5 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - letrozol - 44 - cytostatica
exemestan mylan 25 mg
mylan ireland limited, Írsko - exemestán - 44 - cytostatica
exemestane pharmacenter 25 mg filmom obalené tablety
pharmevid s.r.o., slovensko - exemestán - 44 - cytostatica
exemestane pharos generics 25 mg
farmia, s.r.o., slovensko - exemestán - 44 - cytostatica
letrovena 2,5 mg filmom obalené tablety
vipharm s.a., poľsko - letrozol - 44 - cytostatica